Benzimidazole-based derivatives as privileged scaffold developed for the treatment of the RSV infection: a computational study exploring the potency and cytotoxicity profiles
Respiratory syncytial virus (RSV) has been identified as a main cause of hospitalisation in infants and children. To date, the current therapeutic arsenal is limited to ribavirin and palivizumab with variable efficacy. In this work, starting from a number of in-house series of previously described a...
שמור ב:
Main Authors: | , , , , , , , |
---|---|
פורמט: | ספר |
יצא לאור: |
Taylor & Francis Group,
2017-01-01T00:00:00Z.
|
נושאים: | |
גישה מקוונת: | Connect to this object online. |
תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
אינטרנט
Connect to this object online.3rd Floor Main Library
סימן המיקום: |
A1234.567 |
---|---|
עותק 1 | זמין |